Nine Chapters Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Nine Chapters Capital Management’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-15,400	Closed	-$2.32M	–	1000
2015 Q2	$2.32M	Buy	15,400 +4,000	+35%	+$572K	0.19%	137
2015 Q1	$1.54M	Buy	+11,400	New	+$1.41M	0.13%	222
2014 Q4	–	Sell	-5,700	Closed	-$646K	–	954
2014 Q3	$646K	Buy	+5,700	New	+$675K	0.06%	444
2013 Q3	–	Sell	-4,500	Closed	-$505K	–	768
2013 Q2	$505K	Buy	+4,500	New	+$528K	0.09%	332

Other funds holding BIO

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

LCS

Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nine Chapters Capital Management's BIO Position: Q3 2015 in Review

Nine Chapters Capital Management sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2015, closing a stake of 15,400 shares — an estimated $2.32M sold.

Nine Chapters Capital Management first reported a position in BIO in Q2 2013 and held it in 4 quarters. The position peaked at $2.32M in Q2 2015. 244 funds tracked by Wall St. Rank hold BIO as of Q3 2015.

Nine Chapters Capital Management reported no remaining Bio-Rad Laboratories Class A position as of Q3 2015 after selling out during the quarter.
Nine Chapters Capital Management sold 15,400 Bio-Rad Laboratories Class A shares in Q3 2015, an estimated $2.32M.
Nine Chapters Capital Management first reported a position in Bio-Rad Laboratories Class A in Q2 2013 and held it in 4 quarters.
Nine Chapters Capital Management's Bio-Rad Laboratories Class A position peaked at $2.32M in Q2 2015.
244 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2015.

Based on Nine Chapters Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.